Pharming Group NV 2023 Annual Report with Sustainability Disclosures
Company: Pharming Group NV
Sector: Manufacturing
Country: Netherlands
Year: 2023
Type: Annual Report with Sustainability Disclosures
Pages: 201
The report describes Pharming's transformation into a multi-product commercial rare disease company, including the U.S. launch of Joenja® (leniolisib) for APDS. It reports total revenues of 245.3 million US$ and continued development of its rare disease pipeline. The company also completed a double materiality assessment in accordance with CSRD requirements.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.